These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nitrosoureas: a review of experimental antitumor activity. Schabel FM Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694 [TBL] [Abstract][Full Text] [Related]
3. [In vitro study of estradiol-linked nitrosourea in breast cancers in the mouse, rat and human: interspecies comparison]. Petru E; Berger MR; Zeller WJ; Kaufmann M Wien Klin Wochenschr; 1989 Feb; 101(4):130-4. PubMed ID: 2538970 [TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)]. Zeller WJ; Berger M Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of the transplantable acute leukemia L5222 in rats. Zeller WJ; Ivankovic S; Schmähl D Cancer Res; 1975 May; 35(5):1168-74. PubMed ID: 1120307 [TBL] [Abstract][Full Text] [Related]
6. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma. Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of spin labeled TEPA and CCNU analogs against osteosarcoma and MNU-induced mammary carcinoma of the SD-rat. Klenner T; Berger MR; Sosnovsky G; Rao NU; Wingen F; Schmähl D Arch Geschwulstforsch; 1989; 59(4):251-6. PubMed ID: 2478094 [TBL] [Abstract][Full Text] [Related]
8. Retinoid feeding, hormone inhibition, and/or immune stimulation and the progression of N-methyl-N-nitrosourea-induced rat mammary carcinoma: suppression by retinoids of peptide hormone-induced tumor cell proliferation in vivo and in vitro. Welsch CW; DeHoog JV; Scieszka KM; Aylsworth CF Cancer Res; 1984 Jan; 44(1):166-71. PubMed ID: 6360344 [TBL] [Abstract][Full Text] [Related]
9. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities. Eisenbrand G IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062 [TBL] [Abstract][Full Text] [Related]
10. In vitro investigations on the antineoplastic effect of hexadecylphosphocholine. Yanapirut P; Berger MR; Reinhardt M; Schmähl D Arzneimittelforschung; 1991 Jun; 41(6):652-5. PubMed ID: 1930356 [TBL] [Abstract][Full Text] [Related]
11. [Cure of acute leukaemia L 5222 in rats by a single course of treatment with vincristin and cyclophosphamide, or 1,3-bis-(2-chloroethyl)-1-nitroso-urea (BCNU) and cyclophosphamide (author's transl)]. Zeller WJ; Schmähl D; Ivankovic S Dtsch Med Wochenschr; 1974 Jun; 99(25):1367-8. PubMed ID: 4836074 [No Abstract] [Full Text] [Related]
12. Biological activity of hydroxylated chloroethylnitrosoureas. Zeller WJ; Frühauf S; Chen G; Eisenbrand G; Lijinsky W Cancer Res; 1989 Jun; 49(12):3267-70. PubMed ID: 2720679 [TBL] [Abstract][Full Text] [Related]
13. Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors. Ben-Hur H; Kossoy G; Zandbank J; Zusman I Int J Mol Med; 2002 Apr; 9(4):425-30. PubMed ID: 11891540 [TBL] [Abstract][Full Text] [Related]
14. Effects of cyclophosphamide and soluble tumor-associated antigens on lymphoid infiltration, proliferative activity and rate of apoptosis in chemically-induced rat mammary tumors. Ben-Hur H; Kossoy G; Tendler Y; Kossoy N; Zusman I In Vivo; 2002; 16(5):287-92. PubMed ID: 12494865 [TBL] [Abstract][Full Text] [Related]
15. Increased efficacy and reduced cardiotoxicity of metronomic treatment with cyclophosphamide in rat breast cancer. Todorova VK; Kaufmann Y; Klimberg VS Anticancer Res; 2011 Jan; 31(1):215-20. PubMed ID: 21273601 [TBL] [Abstract][Full Text] [Related]
16. [Analysis of chemosensitivity against a human breast cancer xenograft (MX-1) with the subrenal capsule assay in BDF1 mice]. Inoue K; Wang Y; Tada A; Ueno K; Kojima K; Ogawa M Gan To Kagaku Ryoho; 1985 Aug; 12(8):1644-50. PubMed ID: 4026333 [TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models. Schmid FA; Sirotnak FM; Otter GM; DeGraw JI Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784 [TBL] [Abstract][Full Text] [Related]
18. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model. Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538 [TBL] [Abstract][Full Text] [Related]
19. Acute in vivo resistance in high-dose therapy. Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940 [TBL] [Abstract][Full Text] [Related]
20. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta. Borden EC; Sidky YA; Hatcher JF; Bryan GT Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]